0001127602-23-007927.txt : 20230301
0001127602-23-007927.hdr.sgml : 20230301
20230301165302
ACCESSION NUMBER: 0001127602-23-007927
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230228
FILED AS OF DATE: 20230301
DATE AS OF CHANGE: 20230301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAIN ALAN J
CENTRAL INDEX KEY: 0001227372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30111
FILM NUMBER: 23694520
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001062822
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 760474169
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2445 TECHNOLOGY FOREST BLVD.
STREET 2: SUITE 1100
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
BUSINESS PHONE: 2818633000
MAIL ADDRESS:
STREET 1: 2445 TECHNOLOGY FOREST BLVD.
STREET 2: SUITE 1100
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE
DATE OF NAME CHANGE: 20070426
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON GENETICS INC/TX
DATE OF NAME CHANGE: 20000126
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2023-02-28
0001062822
LEXICON PHARMACEUTICALS, INC.
LXRX
0001227372
MAIN ALAN J
2445 TECHNOLOGY FOREST BLVD.
11TH FLOOR
THE WOODLANDS
TX
77381
1
EVP, Innov & Chem Sciences
Common Stock
2023-02-28
4
M
0
23300
A
198889
D
Common Stock
2023-02-28
4
M
0
8976
A
207865
D
Common Stock
2023-02-28
4
M
0
25667
A
233532
D
Common Stock
2023-02-28
4
F
0
20946
2.17
D
212586
D
Restricted Stock Units
2023-02-28
4
M
0
23300
D
Common Stock
23300
0
D
Restricted Stock Units
2023-02-28
4
M
0
8976
D
Common Stock
8976
8977
D
Restricted Stock Units
2023-02-28
4
M
0
25667
D
Common Stock
25667
51333
D
Each restricted stock unit represents a contingent right to receive one share of common stock.
Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
/s/ Alan J. Main, Ph.D.
2023-03-01